Knowles (NYSE: KN) has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor p
Knowles NYSE: KN has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor pre
Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech &